Identification of Potential HLA-A *0201 Restricted CTL Epitopes Derived from the Epithelial Cell Adhesion Molecule (Ep-CAM) and the Carcinoembryonic Antigen (CEA)
- 31 March 1997
- journal article
- Published by Elsevier in Human Immunology
- Vol. 53 (1) , 81-89
- https://doi.org/10.1016/s0198-8859(97)00032-3
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Peptide-based cancer vaccinesCurrent Opinion in Immunology, 1996
- Peptide-pulsed dendritic cells induce tumoricidal cytotoxic T lymphocytes from healthy donors against stably HLA-A*0201-binding peptides from the Melan-A/MART-1 self antigenEuropean Journal of Immunology, 1996
- Therapy of murine tumors with p53 wild-type and mutant sequence peptide-based vaccines.The Journal of Experimental Medicine, 1996
- Differences and similarities in the A2.1‐restricted cytotoxic T cell repertoire in humans and human leukocyte antigen‐transgenic miceEuropean Journal of Immunology, 1996
- An HLA class I peptide-binding assay based on competition for binding to class I molecules on intact human B cellsHuman Immunology, 1995
- Detailed motifs for peptide binding to HLA-A∗0201 derived from large random sets of peptides using a cellular binding assayHuman Immunology, 1995
- Vaccination with cytotoxic T lymphocyte epitope‐containing peptide protects against a tumor induced by human papillomavirus type 16‐transformed cellsEuropean Journal of Immunology, 1993
- In vitro induction of human cytotoxic T lymphocyte responses against peptides of mutant and wild‐type p53European Journal of Immunology, 1993
- Identification of peptide sequences that potentially trigger HLA‐A2.1‐restricted cytotoxic T lymphocytesEuropean Journal of Immunology, 1993
- A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human MelanomaScience, 1991